Skip to main content

Table 1 Characteristics of the studies included in the meta-analysis

From: Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis

Author

Year

Country

Ethnicity

Follow-up (months)

Treatment

Age (years)

No. of patients

Stage

Cut-off value

Survival analysis

Analysis

NOS

score

Temraz

2014

Lebanon

Caucasian

24

Mixed

65 (43–88)

68

Mixed

2.81

OS/RFS

UV

8

Lee

2015

UK

Caucasian

NA

Surgery

75 (65–81)

226

Early

1.8

OS

MV

7

Zhang

2015

China

Asian

50.8

Mixed

65 (30–78)

124

Mixed

4

OS

MV

8

Yoshida

2015

Japan

Asian

72 (27.6–111.6)

Mixed

72 (43–91)

181

Mixed

3.51

OS

MV

7

Lucca

2016

Austria

Caucasian

NA

Surgery

68 (61–74)

310

Early

3.3

OS

MV

6

D’Andrea

2017

Austria

Caucasian

42.4 (18.3–85.1)

Surgery

67 (60–73)

4198

Mixed

3.5

OS/RFS/CSS

MV

8

Miyake

2017

Japan

Asian

22 (10–64)

Mixed

72 (61–77)

117

Mixed

3.3

OS/CSS

UV

6

Rajwa

2018

Poland

Caucasian

14 (7–40)

Surgery

NA

144

Mixed

2.44

OS/CSS

MV

8

Wang

2018

China

Asian

NA

Mixed

63 (20–85)

270

Early

4

RFS

UV

7

  1. Abbreviations: OS overall survival, RFS recurrence-free survival, CSS cancer-specific survival, MV multivariate, NA not available